Xenon Pharmaceuticals (NASDAQ:XENE) expands its ion channel product pipeline with XEN496 (active ingredient ezogabine), a Kv7 potassium ... read more
Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy
Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy